Skip to main content

SUDAFED® Products

Explore our full range of products for targeted or multi-symptom congestion relief for adults and children.

Sudafed family of products including children's nasal decongestant, nasal spray, and sinus congestion relief

Frequently Asked Questions

A nasal decongestant is a medication that helps relieve nasal congestion such as a stuffy or runny nose. It works by constricting the blood vessels in the nasal passages, which reduces swelling and inflammation. Nasal decongestants are available in various forms, including nasal sprays, caplets, tablets, or liquid.

SUDAFED® products contain pseudoephedrine, which is a decongestant that relieves sinus or nasal congestion. These products are available behind the pharmacy counter.

Pseudoephedrine is an active ingredient in nasal decongestant products that relieves sinus or nasal congestion. It works by narrowing the blood vessels in the nose that are swollen during the common cold, allergies, or flu. When the blood vessels narrow, the tissue shrinks and allows the normal flow of air and mucus. This results in temporary relief of nasal congestion, sinus congestion, and sinus pressure. Decongestants containing pseudoephedrine are packaged in pill or liquid form and can only be found behind-the-counter at your local pharmacy or drug store.

Phenylephrine is a nasal decongestant that works by narrowing the blood vessels in the nose that are expanded during the common cold or allergies. When the blood vessels in the nose and sinuses narrow, the tissue shrinks and allows the normal flow of air and mucus. This results in temporary relief of nasal congestion, sinus congestion, and sinus pressure.

The “OM” in SUDAFED® OM refers to the active ingredient Oxymetazoline, a powerful decongestant used primarily in nasal sprays for the temporary relief of nasal congestion symptoms caused by the common cold or allergies. It works by narrowing blood vessels in the nasal passages to reduce swelling and allow you to breathe more freely.

Don't see your question? Visit our FAQ page.

*On November 8, 2024 the U.S. Food & Drug Administration (FDA) issued a proposed order to remove oral phenylephrine (PE) from the OTC monograph. The FDA proposed order is not related to safety.